| Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter prospective phase 3 … TA Hope, M Eiber, WR Armstrong, R Juarez, V Murthy, C Lawhn-Heath, ... JAMA oncology 7 (11), 1635-1642, 2021 | 251 | 2021 |
| Current and emerging clinical applications of PSMA PET diagnostic imaging for prostate cancer A Farolfi, L Calderoni, F Mattana, R Mei, S Telo, S Fanti, P Castellucci Journal of Nuclear Medicine 62 (5), 596-604, 2021 | 153 | 2021 |
| 68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment … A Farolfi, F Ceci, P Castellucci, T Graziani, G Siepe, A Lambertini, ... European journal of nuclear medicine and molecular imaging 46, 11-19, 2019 | 141 | 2019 |
| EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer—2024 update. Part I: screening, diagnosis, and local treatment with curative intent P Cornford, RCN van den Bergh, E Briers, T Van den Broeck, ... European Urology, 2024 | 125 | 2024 |
| 68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy F Ceci, P Castellucci, T Graziani, A Farolfi, C Fonti, F Lodi, S Fanti European Journal of Nuclear Medicine and Molecular Imaging 46, 31-39, 2019 | 111 | 2019 |
| Prediction nomogram for 68Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancer F Ceci, L Bianchi, M Borghesi, G Polverari, A Farolfi, A Briganti, ... European journal of nuclear medicine and molecular imaging 47, 136-146, 2020 | 64 | 2020 |
| Non-oncologic incidental uptake on FAPI PET/CT imaging M Hotta, AC Rieger, MG Jafarvand, N Menon, A Farolfi, MR Benz, J Calais The British journal of radiology 96 (1142), 20220463, 2023 | 52 | 2023 |
| Patient-and tumour-related prognostic factors for urinary incontinence after radical prostatectomy for nonmetastatic prostate cancer: a systematic review and meta-analysis M Lardas, N Grivas, TPA Debray, F Zattoni, C Berridge, M Cumberbatch, ... European urology focus 8 (3), 674-689, 2022 | 52 | 2022 |
| The evolving role of prostate-specific membrane antigen–based diagnostics and therapeutics in prostate cancer TB Dorff, S Fanti, A Farolfi, RE Reiter, TY Sadun, O Sartor American Society of Clinical Oncology Educational Book 39, 321-330, 2019 | 49 | 2019 |
| Theranostics for advanced prostate cancer: current indications and future developments A Farolfi, W Fendler, A Iravani, U Haberkorn, R Hicks, K Herrmann, J Walz, ... European urology oncology 2 (2), 152-162, 2019 | 49 | 2019 |
| 68Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study A Farolfi, A Gafita, J Calais, M Eiber, A Afshar-Oromieh, F Spohn, ... The Journal of urology 202 (6), 1174-1181, 2019 | 47 | 2019 |
| Response evaluation criteria in PSMA PET/CT (RECIP 1.0) in metastatic castration-resistant prostate cancer A Gafita, L Djaileb, I Rauscher, WP Fendler, B Hadaschik, SP Rowe, ... Radiology 308 (1), e222148, 2023 | 38 | 2023 |
| Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions M Renzulli, N Brandi, G Argalia, S Brocchi, A Farolfi, S Fanti, R Golfieri La radiologia medica 127 (2), 129-144, 2022 | 37 | 2022 |
| EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer D Tilki, RCN van den Bergh, E Briers, T Van den Broeck, O Brunckhorst, ... European Urology, 2024 | 34 | 2024 |
| PSMA and choline PET for the assessment of response to therapy and survival outcomes in prostate cancer patients: a systematic review from the literature P Alongi, R Laudicella, H Lanzafame, A Farolfi, P Mapelli, M Picchio, ... Cancers 14 (7), 1770, 2022 | 30 | 2022 |
| Positron emission tomography and whole-body magnetic resonance imaging for metastasis-directed therapy in hormone-sensitive oligometastatic prostate cancer after primary … A Farolfi, B Hadaschik, FC Hamdy, K Herrmann, MS Hofman, DG Murphy, ... European urology oncology 4 (5), 714-730, 2021 | 26 | 2021 |
| Multicenter external validation of a nomogram for predicting positive prostate-specific membrane antigen/positron emission tomography scan in patients with prostate cancer … L Bianchi, P Castellucci, A Farolfi, M Droghetti, C Artigas, J Leite, ... European Urology Oncology 6 (1), 41-48, 2023 | 25 | 2023 |
| Mapping prostate cancer lesions before and after unsuccessful salvage lymph node dissection using repeat PSMA PET A Farolfi, H Ilhan, A Gafita, J Calais, F Barbato, M Weber, ... Journal of Nuclear Medicine 61 (7), 1037-1042, 2020 | 24 | 2020 |
| Accuracy of 68Ga-PSMA-11 for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: A multicenter prospective phase III imaging study. TA Hope, WR Armstrong, V Murthy, C Lawhn Heath, S Behr, F Barbato, ... Journal of Clinical Oncology 38 (15_suppl), 5502-5502, 2020 | 24 | 2020 |
| Evaluation of an automated module synthesis and a sterile cold kit–based preparation of 68Ga-PSMA-11 in patients with prostate cancer L Calderoni, A Farolfi, D Pianori, E Maietti, V Cabitza, A Lambertini, ... Journal of Nuclear Medicine 61 (5), 716-722, 2020 | 23 | 2020 |
Stefano FantiProfessore di Diagnostica per ImmaginiVerified email at unibo.it
